RxAdvance’s Sculley: What the PBM of the Future Might Look Like
The traditional models for pharmacy benefit managers have been under particular scrutiny of late, with these companies seeing the revival and [...]
Identifying High-Risk COVID Patients Through Early Symptoms and Other Risk Factors
As cases of the coronavirus continue to rise in the US and globally, there is increasing need to find more [...]
Digital Health Outcomes partners with the Institute for Clinical and Economic Review (ICER)
We are celebrating the launch of the next generation interactive modelling platform! Many thanks to our clients and partners, especially [...]
Scientist.com to Acquire HealthEconomics.Com, the World’s Leading Connected Community for Health Economics and Outcomes Research
Scientist.com, the healthcare industry’s leading marketplace for outsourced R&D, announced today it will acquire HealthEconomics.Com, a private US-based company that [...]
[Podcast] The Conflict Between QALYs for Drug Value and Patient Advocacy Groups
In the latest episode of the Relentless Health Value podcast, Stacey Richter interviews Memorial Sloan Kettering’s Anna Kaltenboeck about how [...]
Trump’s Drug-card Plan Hits Another Roadblock
Trump’s plan, which blindsided health officials in September, came as the president sought to reverse declining poll numbers among “our [...]
Pandemic Tames Healthcare Cost Growth for Some Employers
Large U.S. employers saw their smallest health care cost increase in more than two decades due to COVID-19, and workers [...]
ICER Publishes Final Evidence Report on Digital Therapeutics for Opioid Use Disorder
ICER Publishes Evidence Report on Digital Therapeutics for Opioid Use Disorder The Institute for Clinical and Economic Review (ICER) today [...]
Cystic Fibrosis Drug Pricing Violates Human Rights According to Patients
In an unusual move, a coalition of cystic fibrosis patients and their families have filed a complaint with the United [...]
[On-demand Video] Secondary Data First
Secondary data sourced from routinely collected healthcare information is playing a decisive role in stakeholder decision making. Learn how this [...]
COVID-19 and Influenza to be Initial Focus of Google Health Studies App
Google is upping its focus on health research with a new mobile app that lets smartphone users participate in virtual [...]
Trump’s Last Ditch Effort to Change Rx Price Rules
The Trump administration’s 11th hour attempt to bring down high prescription drug costs succeeded in drawing swift condemnation from health [...]
What’s Driving Oncology HTAs in South Korea?
Reimbursement in South Korea depends upon a favorable review by Health Insurance Review Agency (HIRA), and some therapies may not [...]
Google Launches Health Studies App
Google made a major move into health research on Wednesday, unveiling a new smartphone app that lets Android users participate [...]
Outrage Over Google’s Firing of AI Ethicist Timnit Gebru
Google abruptly fired Timnit Gebru last night, an AI ethicist who has tremendous respect around the world for her work [...]
Reshaping of Global Policy by COVID: Implications for Market Access
The COVID-19 pandemic has upended daily lives around the globe and has also created new challenges for life sciences companies [...]
Virtual ISPOR 2021 Issue Panel & Workshop Proposals Due Next Week!
Submit by Wednesday, December 16 for an Opportunity to Present Your Research at Virtual ISPOR 2021! Due to the constraints [...]
Delays in Clinical Trials Present Pharma Companies With Opportunities to Evolve
COVID-19 has upended clinical trial timelines – putting billions of forecasted sales at risk and delaying getting life-saving treatments to [...]
[Webinar] Tumor Profiling for Health Insurance Providers
On December 10, 2020 1:00 PM – 2:00 PM ET, Illumina will host a webinar on comprehensive genomic profiling (CGP). [...]
Using Real World Data to Close the Rare Disease Gap
7,000. That’s the estimated number of distinct types of rare and genetic diseases affecting more than 400 million people around [...]
[Webinar] Setting the Agenda for #46
On December 9, 4pm CST, Optum will host a webinar focusing on healthcare-related issues that will be in the forefront [...]
Data on a Mission: Removing Barriers to Understanding of Rare Disease
Research and drug development for rare and genetic diseases is challenging without insight into history and clinical manifestations. Missing efficacy [...]
Healthcare Artificial Intelligence Market: Global Forecast to 2027
Report Highlights: The global healthcare artificial intelligence (AI) market is expected to grow at a CAGR of 41.4% from 2020 [...]
Six Payer Executives to Watch in 2021
The past year has forced health plans to nimbly adapt to the demands of a global pandemic, including massive spikes [...]
Improving Peer Review in Economics
Three experimental economists, Gary Charness (UCSB), Anna Dreber (SSE) and Severine Toussaert (Oxford), are conducting a 15-20 min anonymous survey [...]